Latest Early Stage Technology News

Enlitic, Inc. has launched a A$10 million placement alongside an offer of 125 million unquoted options, aiming to fuel growth in its AI-driven healthcare technology business. The move underscores both funding ambitions and the complex risks tied to AI adoption and market dynamics.

Cardiex Digital Vascular Biomarkers announces a A$6.5 million equity raise to fund inventory, marketing, product development, and debt repayment, aiming to solidify its position in the expanding cardiovascular health market.

Global uranium enrichment leader Urenco has agreed to invest A$5 million in Australian technology developer Ubaryon, forming a strategic partnership that validates and accelerates a novel uranium enrichment process.

Strategic Elements Ltd (ASX: SOR) reported meaningful progress in its Energy Ink™ technology and underground mining platform during Q1 2025, while maintaining a robust cash balance and preparing for international collaborations.

Bluechiip Limited reported a $221,000 net cash outflow for Q2 FY2025, with cash reserves dwindling to $121,000. The company has initiated a strategic review and plans a capital raise to secure its future.

Identitii reports solid quarterly progress highlighted by a strategic new director appointment, US market expansion, and a successful $1.8 million capital raise, underpinning its path toward profitability.

Scalare Partners reports robust progress in Q2 FY25, highlighted by a $4.3 million capital raise, expansion of its Tech Ready Women program, and a growing investment portfolio. The company is poised for its next growth phase with a strong cash position and a healthy pipeline of early-stage tech investments.